What is APYX's market cap?

$109.52M, based on the Nov 4 close of $2.60.

Does Apyx Medical pay a dividend?

No regular cash dividend has been paid in the last year.

How much of APYX is sold short?

213.7K shares, 0.7% of float, as of Oct 15, 2026.

What sector is APYX in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · APYXHealthcareSurgical Instruments

Apyx Medical Corporation Common Stock (APYX)

$2.600.00%

Close Nov 4, 2026 · split-adjusted

Nov 3, 2026$2.60▼ 18.75% in range

Nov 3, 2025Low $2.36 · High $4.86Nov 3, 2026

What changed · written from our data

As of Nov 4, 2026

Apyx Medical closed at $2.60 on Nov 4, unchanged, 46.5% below its 52-week closing high. Volume of 49.0K shares was 0.42× its 20-day average (below normal).

Split-adjusted performance: +2.2% over one month, -11.0% over six months, -18.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $13.88M, up 22.1% from a year earlier, with a net margin of -23.4%.

Short interest was 213.7K shares at the Oct 15 settlement, up 3.3% from the prior report (0.7% of float, 1.8 days to cover).

Market cap$109.5M42.1M shares

Revenue · quarter$13.9M+22.1% YoY

Diluted EPS$-0.07—

P/E · TTM—P/S 1.9×

Net margin-23.4%Gross 63.9%

Dividend yieldNone

52-week range2.36 – 4.86−46.5% from high

Volume49.0K0.42× 20-day avg

Volatility · 60d57.5%Annualised

Short % of float0.7%1.8 days to cover

Net cash-$7.7MCash $27.6M

Next earnings—Not scheduled

Split-adjusted performance

1W −0.4%1M +2.2%3M −37.5%6M −11.0%YTD −25.7%1Y −18.8%3Y +13.5%5Y −81.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum44

Revenue growth81

Net margin41

Value (low P/E)—

Size39

Industry medians: 6-month return −4.4%, revenue growth +8.9%, net margin −8.2%, P/E 29.7×.

Short interest

Details →

Shares short213.7K+3.3% vs prior

Days to cover1.8Settled Oct 15

% of float0.7%

Short vol. 10d38.7%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
APYXApyx Medical	$2.60	0.00%	−11.0%	+22.1%	−23.4%	—	$109.5M
LUNGPulmonx	$2.86	+4.96%	+121.3%	−4.6%	−44.3%	—	$122.6M	Compare
LUCDLucid Diagnostics	$0.4539	+10.98%	−58.0%	+26.7%	−998.3%	—	$86.7M	Compare
KRMDKORU Medical Systems, Inc. Common Stock (DE)	$3.27	+5.48%	−18.5%	+18.2%	2.1%	—	$151.0M	Compare
MBOTMicrobot Medical	$1.14	+4.13%	−48.2%	—	−2334.9%	—	$76.2M	Compare
SKINSkinHealth Systems	$10.95	+5.80%	−41.3%	−7.8%	−3.7%	—	$71.3M	Compare
LNSRLENSAR	$5.75	+3.14%	+6.7%	+18.4%	10.7%	4.6	$70.6M	Compare
PDEXPro-Dex Inc New	$63.00	+4.58%	+7.7%	+11.0%	14.8%	16.8	$201.6M	Compare
NEGGNewegg Commerce	$9.64	+4.90%	−69.7%	—	—	—	$202.2M	Compare

News about Apyx Medical

All news →

New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®GlobeNewswire Inc. · May 21, 2026▲ Positive Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™GlobeNewswire Inc. · May 11, 2026▲ Positive

Quick answers

What does Apyx Medical do?: Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals.
What is APYX's market cap?: $109.52M, based on the Nov 4 close of $2.60.
Does Apyx Medical pay a dividend?: No regular cash dividend has been paid in the last year.
How much of APYX is sold short?: 213.7K shares, 0.7% of float, as of Oct 15, 2026.
What sector is APYX in?: Healthcare, in the Surgical Instruments industry.

About Apyx Medical

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

HQ: Clearwater, FL205 employeesListed Apr 6, 1994apyxmedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology